Editor-in-Chief & Deputy Editor 2019-2021

 

Editor-in-Chief:

Nicolas LANTHIER

 

Deputy Editor:

Tim VANUYTSEL

 

 
Safety and cost of infliximab for the treatment of belgian pediatric patients with Crohn’s diseaseSafety of biologics : current issues and future concerns

Safety assessment in Child A cirrhotic patients treated with Ombitasvir/Paritaprevir/Ritonavir and Dasabuvir with Ribavirin

Price: €10,00








E.D. Manea1, I. Stefan2,3, C. Olariu4, O.C. Calina1, R.E. Jipa1, A. Hristea1,4

(1) “Prof. Dr. Matei Bals” National Institute for Infectious Diseases, Bucharest, Romania ; (2) “Dr. Carol Davila” Central Military Emergency University Hospital,
Bucharest, Romania ; (3) 3 “Titu Maiorescu” University, Bucharest, Romania ; (4)4 “Carol Davila” University of Medicine and Pharmacy, Bucharest, Romania .